Topical Vancomycin is More Efficient than Povidone-Iodine Treatment in Controlling Bacterial Growth in Methicillin-Resistant Staphylococcus Aureus Keratitis Model in Rabbits.

IF 1.7 4区 医学 Q3 OPHTHALMOLOGY
Current Eye Research Pub Date : 2024-09-01 Epub Date: 2024-05-06 DOI:10.1080/02713683.2024.2349661
Yunus Alkan, Abdulgani Kaymaz, Mustafa Behcet, Abdullah Bayrak
{"title":"Topical Vancomycin is More Efficient than Povidone-Iodine Treatment in Controlling Bacterial Growth in Methicillin-Resistant <i>Staphylococcus Aureus</i> Keratitis Model in Rabbits.","authors":"Yunus Alkan, Abdulgani Kaymaz, Mustafa Behcet, Abdullah Bayrak","doi":"10.1080/02713683.2024.2349661","DOIUrl":null,"url":null,"abstract":"<p><p>To evaluate the efficacy of topical vancomycin and povidone iodine (PI) application on methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) keratitis model in rabbits.</p><p><p>MRSA keratitis was induced by injecting 0.1 mL MRSA containing 1000 colony-forming units (CFU) into central cornea of right eyes of 24 New Zealand White rabbits. Animals were divided into four groups (<i>n</i> = 6): control (treated with balanced salt solution), 50 mg/mL topical vancomycin, 5% topical PI, and combination; examined before and after treatment, and corneal tissues were harvested for analysis at 9th hour of treatment.</p><p><p>Bacterial load was determined as: 7.63 ± 0.82 log10 CFU/g in control group, 6.95 ± 1.66 log10 CFU/g in PI group, 4.67 ± 0.77 log10 CFU/g in combination group, and 4.33 ± 0.71 log10 CFU/g in vancomycin group (<i>p</i> = 0.001). Median of total clinical score increased significantly from 7 [range: 5-8] to 11.5 [range: 11-15] (<i>p</i> = 0.001) in control group, did not change (6 [range: 5-8] to 7 [range: 5-7]; <i>p</i> = 0.695) in vancomycin group, increased significantly from 7 [range: 5-8] to 12.5 [range: 10-14] (<i>p</i> < 0.001) in PI group, increased significantly from 6.5 [range: 5-7] to 8 [range: 7-9] in combination group (<i>p</i> = 0.002). Post-treatment clinical scores for chemosis, conjunctival injection, iritis, hypopyon, epithelial erosion, and corneal infiltrate were significantly lower in vancomycin-treated groups compared to others (<i>p</i> < 0.05). In PI-treated groups, especially scores for chemosis, conjunctival injection, epithelial erosion and corneal infiltrate were significantly higher than vancomycin (<i>p</i> < 0.05).</p><p><p>Topical vancomycin significantly inhibited bacterial growth in MRSA keratitis. However, PI was ineffective in controlling this growth; additionally, exerted toxic effect on ocular surface. When vancomycin was combined with PI, no additional increase in efficacy of treatment was detected compared to only vancomycin.</p>","PeriodicalId":10782,"journal":{"name":"Current Eye Research","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Eye Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/02713683.2024.2349661","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/6 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

To evaluate the efficacy of topical vancomycin and povidone iodine (PI) application on methicillin-resistant Staphylococcus aureus (MRSA) keratitis model in rabbits.

MRSA keratitis was induced by injecting 0.1 mL MRSA containing 1000 colony-forming units (CFU) into central cornea of right eyes of 24 New Zealand White rabbits. Animals were divided into four groups (n = 6): control (treated with balanced salt solution), 50 mg/mL topical vancomycin, 5% topical PI, and combination; examined before and after treatment, and corneal tissues were harvested for analysis at 9th hour of treatment.

Bacterial load was determined as: 7.63 ± 0.82 log10 CFU/g in control group, 6.95 ± 1.66 log10 CFU/g in PI group, 4.67 ± 0.77 log10 CFU/g in combination group, and 4.33 ± 0.71 log10 CFU/g in vancomycin group (p = 0.001). Median of total clinical score increased significantly from 7 [range: 5-8] to 11.5 [range: 11-15] (p = 0.001) in control group, did not change (6 [range: 5-8] to 7 [range: 5-7]; p = 0.695) in vancomycin group, increased significantly from 7 [range: 5-8] to 12.5 [range: 10-14] (p < 0.001) in PI group, increased significantly from 6.5 [range: 5-7] to 8 [range: 7-9] in combination group (p = 0.002). Post-treatment clinical scores for chemosis, conjunctival injection, iritis, hypopyon, epithelial erosion, and corneal infiltrate were significantly lower in vancomycin-treated groups compared to others (p < 0.05). In PI-treated groups, especially scores for chemosis, conjunctival injection, epithelial erosion and corneal infiltrate were significantly higher than vancomycin (p < 0.05).

Topical vancomycin significantly inhibited bacterial growth in MRSA keratitis. However, PI was ineffective in controlling this growth; additionally, exerted toxic effect on ocular surface. When vancomycin was combined with PI, no additional increase in efficacy of treatment was detected compared to only vancomycin.

在耐甲氧西林金黄色葡萄球菌兔角膜炎模型中,外用万古霉素比聚维酮碘更有效地控制细菌生长。
向 24 只新西兰白兔的右眼中央角膜注射 0.1 mL 含有 1000 菌落总数(CFU)的 MRSA,诱发 MRSA 角膜炎。动物分为四组(n = 6):对照组(用平衡盐溶液处理)、50 mg/mL 万古霉素外用组、5% PI 外用组和混合组;在处理前后进行检查,并在处理后第 9 小时采集角膜组织进行分析:对照组细菌量为 7.63 ± 0.82 log10 CFU/g,PI 组为 6.95 ± 1.66 log10 CFU/g,联合组为 4.67 ± 0.77 log10 CFU/g,万古霉素组为 4.33 ± 0.71 log10 CFU/g(P = 0.001)。对照组临床总分的中位数从 7 [范围:5-8] 显著增加到 11.5 [范围:11-15] (p = 0.001),万古霉素组没有变化(6 [范围:5-8] 到 7 [范围:5-7];p = 0.695),从 7 [范围:5-8] 显著增加到 12.5 [范围:10-14](p p = 0.002)。与其他组相比,万古霉素治疗组的化脓、结膜注射、虹膜炎、眼睑下垂、上皮糜烂和角膜浸润的治疗后临床评分明显降低(p p 局部万古霉素能明显抑制 MRSA 角膜炎的细菌生长。然而,PI 并不能有效控制细菌的生长,而且还会对眼表产生毒性作用。当万古霉素与 PI 联合使用时,与仅使用万古霉素相比,未发现疗效有额外的提高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Eye Research
Current Eye Research 医学-眼科学
CiteScore
4.60
自引率
0.00%
发文量
163
审稿时长
12 months
期刊介绍: The principal aim of Current Eye Research is to provide rapid publication of full papers, short communications and mini-reviews, all high quality. Current Eye Research publishes articles encompassing all the areas of eye research. Subject areas include the following: clinical research, anatomy, physiology, biophysics, biochemistry, pharmacology, developmental biology, microbiology and immunology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信